In symptomatic HF, sacubitril–valsartan vs. dapagliflozin and torsemide vs. furosemide did not differ for health status at 6 mo

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2026-08-03
DOI
https://doi.org/10.7326/annals-26-02647-jc
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In symptomatic HF, sacubitril–valsartan vs. dapagliflozin and torsemide vs. furosemide did not differ for health status at 6 mo

Daniel Steinberg
Annals of Internal Medicine
Diabetes Treatment and Management
article

In symptomatic HF, sacubitril–valsartan vs. dapagliflozin and torsemide vs. furosemide did not differ for health status at 6 mo

Daniel Steinberg
article en

Abstract

No abstract available for this paper.
Annals of Internal Medicine
Maimonides Medical Center (US)
Zero hunger
Openalex Percentile: Top 10%
Diabetes Treatment and Management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.